Autopsy report · NCT00770354
Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer
Cause of deathNo reason given
Life of this trial
- Ran for about 2 years 11 months before it stopped.
- 110 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Antisoma Research
- Sponsor type
- Industry
- Conditions
- Breast Carcinoma
- Interventions
- AS1402; Letrozole
- Participants
- 110 (planned, not actual)
- Sites
- 2
- Countries
- Russia
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.